Combined with the aforementioned studies, an assumption was made that Nrf2 may inhibit the activity of RFC4 by interacting with the RFC4 promoter region in AML cells, thereby leading to gene-instability resistance. The gene discussed is NFE2L2; the disease is acute myeloid leukemia.